TL;DR:
• CoreWeave stock plunges 14% on wider-than-expected Q2 losses
• Company missed EPS estimates by 6 cents despite tripling revenue to $1.21B
• IPO lockup expires Thursday, potentially flooding market with insider shares
• Analysts cite capital expenditure delays and Core Scientific acquisition uncertainty
CoreWeave shares are cratering 14% after the AI infrastructure darling reported a surprise earnings miss just hours before its post-IPO lockup period expires. The timing couldn't be worse for the company that's become synonymous with the AI boom's infrastructure gold rush.
CoreWeave just handed Wall Street a reality check on AI infrastructure valuations. The company's stock is tumbling 14% after reporting an adjusted loss of 27 cents per share, missing analyst expectations by 6 cents in what should have been a triumphant second quarter as a public company.
The timing couldn't be more precarious. CoreWeave's lockup period expires Thursday evening, potentially unleashing a flood of insider selling just as investor confidence wavers. "We remain constructive long term and are encouraged by today's data points, but see near-term upside capped by the potential CORZ related dilution and uncertainty, and the pending lock-up expiration on Thursday," Stifel analysts warned, referencing the company's recent Core Scientific acquisition.
The earnings miss stings particularly because CoreWeave actually delivered spectacular revenue growth, more than tripling year-over-year to $1.21 billion and beating Wall Street's $1.08 billion forecast. Finance chief Nitin Agrawal told analysts that demand still outweighs supply across their AI data center network, which serves marquee clients including OpenAI, Microsoft, and Nvidia.
But investors are fixated on the bottom line deterioration and what it signals about the company's path to profitability. CoreWeave also raised full-year revenue guidance to between $5.15 billion and $5.35 billion, up from previous forecasts, yet the market's focus remains squarely on mounting losses and execution concerns.
Morgan Stanley analysts highlighted a key worry: delayed capital expenditures until the fourth quarter. "This delay in capex highlights the uncertainty around deployment time; as go-live timing is pushed, in-period revenue recognition will be smaller," they wrote. The timing suggests CoreWeave may be struggling with the complex logistics of scaling AI infrastructure fast enough to meet surging demand.
The Core Scientific acquisition adds another layer of uncertainty. Shares of the bitcoin miner turned AI infrastructure play fell 7% Wednesday, dragging down sentiment around the entire AI data center ecosystem. The deal represents CoreWeave's bet on expanding beyond its cloud-native roots into traditional data center real estate, but integration risks loom large.
Meanwhile, CoreWeave completed its $1.4 billion acquisition of AI model monitoring startup Weights and Biases during the quarter, adding to an already complex integration challenge. The company finished Q2 with a massive $30.1 billion revenue backlog, suggesting long-term demand visibility remains strong despite near-term execution headwinds.
The stock's 14% plunge marks a sharp reversal from CoreWeave's meteoric rise since going public in March. Early investors who believed the company would become the infrastructure backbone of the AI revolution now face their first major test of conviction as the lockup expiration threatens to amplify selling pressure.
The market's harsh reaction to CoreWeave's mixed results signals a maturing phase for AI infrastructure investments. While revenue growth remains explosive and demand fundamentals stay strong, investors are demanding clearer paths to profitability and smoother operational execution. With the lockup expiration looming and integration challenges mounting, CoreWeave faces its biggest test yet in proving it can deliver the margins that justify its premium valuation in an increasingly competitive AI infrastructure landscape.
